Paul D. Rubin
Chief Medical Officer · BioAge Labs, Inc.
- 2025
- Apr 3, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul D. Rubin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kristen Fortney - $4.22M in BIOA purchases and sales in the last 12 months
- Shane Barton - $1.58M in BIOA purchases and sales in the last 12 months
- Dov A. Md Goldstein - $532K in BIOA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul D. Rubin?
Paul D. Rubin is a corporate insider, tracked as Chief Medical Officer of BioAge Labs, Inc. (BIOA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Paul D. Rubin last file a Form 4?
The most recent primary Form 4 on record is dated 3 April 2026, one of 5 filings going back to 2025.
Has Paul D. Rubin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.15M) across all tracked filings.
